Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2016-11, Vol.51 (11), p.1510-1512
Hauptverfasser:	Horn, B, O'Kane, S, Wattier, R L, Wahlstrom, J T, Melton, A, Cowan, M J, Dvorak, C C
Format:	Artikel
Sprache:	eng
Schlagworte:	692/1807/1490 692/308/2171 Bacteremia Bone marrow Cell Biology Complications and side effects Development and progression Globulins Health risks Hematology Hematopoietic stem cell transplantation Hematopoietic stem cells Internal Medicine letter-to-the-editor Medicine Medicine & Public Health Monoclonal antibodies Pediatric diseases Pediatrics Public Health Risk factors Stem cell transplantation Stem Cells Thymocytes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!